newly
diagnosed
treatment
information
research &
trials
webcasts find
support
seminars
& meetings
events doctors nurses advocacy about
IMF
helping
the IMF
 
      Scientific Advisory Board     
 

:
Help fund research and important educational programs.
more..

WHAT IS MYELOMA? : more..


PATIENT SERVICES : Reimbursement, legal, and other services.
more..

MYELOMA MANAGER™ : Capture your lab results and see how they change over time. more..

NEXPROFILER™ :
Treatment information tailored to your diagnosis.
more..

FREE MYELOMA INFO PACK : Order one today. more..

Read the MYELOMA MINUTE :
Our free e-mail newsletter.
more..

Read MYELOMA TODAY :
And get a free subscription.
more..

IMF Privacy Policy : The IMF is committed to protecting the security of your personal and health information. more..

Share via del.icio.us Share via Digg SCIENTIFIC ADVISORY BOARD

The IMF is fortunate to have a distinguished Board Of Scientific Advisors comprised of 47 members, who are world recognized experts in the field of multiple myeloma. This board provides valuable counsel and supports the IMF's goals in education, treatment and research.
Chairman:
  Robert A. Kyle, MD, Chairman
  Mayo Clinic
Rochester, MN
U.S.A.
Scientific Advisors:
  Raymond Alexanian, MD
  M.D. Anderson Cancer Center
Houston, TX
U.S.A.
  Kenneth C. Anderson, MD
  Dana-Farber Cancer Institute
Boston, MA
U.S.A.
  Michel Attal, MD
  Hôpital Purpan
Toulouse, France
  Herve Avet-Loiseau, MD
  Institut de Biologie, Nantes, France
  Dalsu Baris, MD, PhD
  Staff Scientist
Division of Cancer Epidemiology
National Cancer Institute (NCI)
Bethesda, Maryland
USA
  Bart Barlogie, MD, PhD
  Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock, Arkansas

U.S.A.
  Régis Battaile, MD
  Central Laboratory of Hematology
Institute of Biology
Nantes, France
  Meral Beksac, MD
  Ankara University
Ibn Sina Hospital
Ankara, Turkey
  William Bensinger, MD
  University of Washington
Fred Hutchinson Cancer Research Center
Seattle , WA
U.S.A.
  James R. Berenson, MD
  Institute for Myeloma & Bone Cancer Research
Los Angeles, CA
U.S.A.
  P. Leif Bergsagel, MD
  Mayo Clinic
Scottsdale, AZ
USA
  Joan Bladé, MD
  Hospital Clinic
Hematology
Barcelona, Spain
  Mario Boccadoro, MD
  Cattedra Di Ematologia
Torino, Italy
  J. Anthony Child, MD
  Chief Investigator of the MRC Myeloma IX Study
Clinical Trials and Research Unit
University of Leeds
Leeds, U.K.
  Raymond L. Comenzo, MD
  Memorial Sloan Kettering Cancer Research Center
New York, NY
U.S.A.
  John Crowley, PhD
  Cancer Research and Biostatistics (CRAB)
Seattle, Washington, U.S.A.
  Franco Dammacco, MD
University of Bari Medical School
Bari, Italy
  Faith Davies, MD
  The Royal Marsden NHS Foundation Trust
Sutton, Surrey, UK
  Meletios-Athanassios Dimopoulos, MD
  Alexandra Hospital
Athens, Greece
  Johannes Drach, MD
  University Hospital Vienna
Vienna, Austria
  Brian G.M. Durie, MD
  Cedars-Sinai Comprehensive Cancer Center
Los Angeles, CA
U.S.A.
  Hermann Einsele, MD
  Hermann Einsele, MD
Universitätsklinikums Würzburg
(University Clinic of Wuerzburg)
Würzburg, Germany
  Dorotea Fantl, MD
  Sociedad Argentinade Hematolgia
Buenos Aries, Argentina
  Rafael Fonseca, MD
  The Mayo Clinic
Scottsdale, Arizona
  Gösta Gahrton, MD
  Karolinska Institute
Huddinge University Hospital
Stockholm, SWEDEN
  Morie A. Gertz, MD
  Mayo Clinic
Rochester, MN
U.S.A.
  John Gibson, MD
  Royal Prince Alfred Hospital
Camperdown, NSW, Australia
  Hartmut Goldschmidt, MD
  Medizinischen Universitätsklinik und Poliklinik V
University of Heidelberg
Heidelberg, Germany
  Roman Hajek, MD
  University Hospital Brno
Brno, Czech Republic
  Jean-Luc Harousseau, MD
  Hematologie Clinique
CHU Hotel Dieu
Nantes, France
  Joy Ho, MD
Royal Prince Alfred Hospitals
and Concord Hospitals
Camperdown, Australia
  Vania Hungria, MD
  Clinica São Germano
São Paulo, Brazil
  Mohamad Hussein, MD
  H. Lee Moffitt Cancer Center
Tampa, Florida
USA
  Sundar Jagannath, MD
  St. Vincent's Comprehensive Cancer Center
New York, NY
U.S.A.
  Douglas Joshua, MD
  Royal Prince Alfred Hospital
Camperdown, NSW, Australia
  Michio M. Kawano, MD
  Graduate School of Medicine
Yamaguchi University
Yamaguchi, Japan
  Henk M. Lokhorst, MD
  University Hospital Utrecht
Utrecht, Netherlands
  Sagar Lonial, MD
  Winship Cancer Institute
Emory University
Atlanta, GA
USA
  Heinz Ludwig, MD
  Wilhelminenspital der Stadt Wein
Vienna, Austria
  Jayesh Mehta, MD
  Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL
U.S.A.
  Håken Mellstedt, MD, PhD
  Karolinska Hospital
Stockholm, Sweden
  Giampaolo Merlini, MD
  Amyloidosis Centre
Università di Pavia
Pavia, Italy
  Gareth Morgan, MD
  The Royal Marsden Hospital
Sutton, Surrey, UK
  Gregory R. Mundy, MD
  Director, Vanderbilt Center for Bone Biology
Nashville, TN
U.S.A
  Nikhil Munshi, MD
  Dana Farber Cancer Institute
Boston MA, USA
  Amara Nouel, MD
  Hospital Rutz y Paez
Bolivar, Venezuela
  Antonio Palumbo, MD
  Ospedale Molinette
Torino, Italy
and Italian Multiple Myeloma Study Group (GISMM
  Linda Pilarski, MD
  Cross Cancer Institute
University of Alberta
Edmonton, Alberta, Canada
  Raymond Powles, MD
  Leukaemia and Myeloma Units
Parkside Oncology Clinic
London, U.K.
  S. Vincent Rajkumar, MD
  Mayo Clinic College of Medicine
Rochester, MN
U.S.A.
  Donna E. Reece, MD
  Princess Margaret Hospital
Toronto, Canada
  Paul G. Richardson, MD
  Dana Farber Cancer Institute
Boston, MA
U.S.A.
  Angelina Rodriguez Morales, MD
  Banco Municipal de Sangre de la Region Capital
Caracas,Venezuela
  David Roodman, MD
  VA Medical Hospital
Pittsburgh, PA
U.S.A.
  Jesús San Miguel, MD
  Hospital Clinico Universitario
Universidad de Salamanca
Salamanca, Spain
  Orhan Sezer, MD
  Medizinische Klinik und Poliklinik II
Berlin, Germany
  Kazayuki Shimizu, MD
  Nagoya City Higashi General Hospital
Nagoya, Japan
  Chaim Shustik, MD
  Royal Victoria Hospital
McGill University Clinical Research Program
Montreal, Canada
  David Siegel, MD
  Hackensack University Medical Center
Hackensack, New Jersey U.S.A
  Seema Singhal, MD
  Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL
U.S.A.
  Alan Solomon, MD
  University of Tennessee Medical Center
Knoxville, TN
U.S.A.
  Pieter Sonneveld, MD
  University Hospital Rotterdam Dijkzigt
Rotterdam, The Netherlands
  Andrew Spencer, MD
Cabrini Hospital
Malvern, Victoria
Australia
  A. Keith Stewart, MD
  Mayo Clinic
Scottsdale, AZ, USA
  Guido Tricot, MD
  Huntsman Cancer Institute
Salt Lake City, Utah
USA
  Benjamin Van Camp, MD, PhD
  Academic Hospital
Free University of Brussels
Brussels, Belgium
  Brian Van Ness, Ph.D.
  University of Minnesota
Institute of Human Genetics
Minneapolis, MN
U.S.A.
  David Vesole, MD
  Director
Loyola University Health System
Blood and Marrow Transplant Program
Chicago, Illinois
  Jan Westin, MD
  Department of Hematology
Sahlgrenska University Hospital
Gothenburg University, Sweden
Scientific Advisors Emeriti:
  Y.C. Chen, MD
  Taiwan National University Hospital
Taiwan, R.O.C.
  Ian M. Franklin, MD
  Royal Infirmary
Glasgow, Scotland
U.K.
  Tadamitsu Kishimoto, MD, Ph.D.
Institute for Molecular & Cellular Biology
Osaka University Medical School
Osaka, Japan
  Ian Mclennan, MD
University of Birmingham, The Medical School
Birmingham, UK
  James S. Malpas, MD
  St. Bartholomew's Hospital
London, England
UK

We thank our web site sponsors

Amgen

Binding Site

Celgene Corporation

Proteolix

We welcome our international partners:
Canada Czech Republic Europe Israel Japan Latin America
Copyright 2009. International Myeloma Foundation. All Rights Reserved.

International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
USA
phone: 800-452-2873 (US and Canada)
818-487-7455 (elsewhere)
fax: 818-487-7454
email: TheIMF@myeloma.org